Skip to main content
SpringerLink
Log in

Cost of antihypertensive treatment: A point of view from India

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

In India, expenditure on the treatment of all patients with mild hypertension is not cost effective. Nonpharmacologic treatment is encouraged.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Mathur KS, Wahi PN, Galhaut DS. Blood pressure studies in the adult population of Agra (India).Am J Card 1963;11:61–65.

    PubMed  Google Scholar 

  2. Gupta SP, Siwach SB, Moda VK. Epidemiology of hypertension based on total community survey in the rural population of Haryana.Ind Heart J 1978;29:53–62.

    Google Scholar 

  3. Gupta SP, Siwach SB, Moda VK. Epidemiology of hypertension based on total community survey in the urban population of Haryana.Ind Heart J 1978;30:315–322.

    Google Scholar 

  4. Wasir HS, Ramachandran P, Nath LM. Prevalence of hypertension in a closed urban community.Ind Heart J 1984;36:250–253.

    Google Scholar 

  5. Dalal PM. Community survey of hypertension in “old” Bombay. In: Thurn RH (ed).Essential Hypertension. Miami: Symposia Specialists, Inc., 1979:35.

    Google Scholar 

  6. Sapru RP. Cardiovascular and nontubercular chest disease. An estimate of the size of the problem in India.Ann Natl Acad Med Sci (India) 1983;19:179–193.

    Google Scholar 

  7. Veterans Administration Cooperative study group on antihypertensive agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg.JAMA 1967;203:1028–1034.

    Google Scholar 

  8. Veterans Administration Cooperative study group on antihypertensive agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mmHg.JAMA 1970;213:1143–1152.

    Google Scholar 

  9. Kannel WB. Importance of hypertension as a major risk factor in cardiovascular disease. In: Genest J, Koiw E, Kuchel O (eds).Hypertension. Physiopathology and treatment. New York: McGraw Hill, 1977:888–909.

    Google Scholar 

  10. Julius S, Hanson L. Borderline hypertension: Epidemiology and clinical implications. In: Genest J, Kuchel O, Hamet P, Cantin M (eds).Hypertension. Physiopathology and Treatment. New York: McGraw Hill, 1983:753.

    Google Scholar 

  11. Report of the management committee. The Australian therapeutic trial in mild hypertension.Lancet 1980;1:1261–1267.

    Google Scholar 

  12. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension.JAMA 1979;242:2562–2571.

    Google Scholar 

  13. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: Principal results.Br Med J 1985;291:97–104.

    Google Scholar 

  14. MacMohan SW, Cutler JA, Furberg CD, Payne GH. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease. A review of randomised controlled trials.Prog Cardiovasc Dis 1986;29 (Suppl 1):99–114.

    PubMed  Google Scholar 

  15. Weber MA. Cardiovascular outcomes of treating high blood pressure.Am Heart J 1987;114:964–971.

    PubMed  Google Scholar 

  16. Joos C, Kewitz H, Reinhold-Korniate DR. Effects of diuretics on plasma lipoproteins in healthy men.Eur J Clin Pharmacol 1980;17:251–257.

    PubMed  Google Scholar 

  17. Ames RP, Hill P. Increase in serum lipids during treatment of hypertension with chlorthalidone.Lancet 1976;1:721–723.

    PubMed  Google Scholar 

  18. Ames RP. The influence of non-beta-blocking drugs on the lipid profile: Are diuretics outclassed as initial therepy for hypertension?Am Heart J 1987;114:998–1006.

    PubMed  Google Scholar 

  19. Lewis PJ, Kohner EM, Petrie A, et al. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment.Lancet 1976;2:1293–1295.

    Google Scholar 

  20. Murphy MB, Lewis PJ, Kohner EM, et al. Glucose intolerance in hypertensive patients treated with diuretics; a fourteen year follow-up.Lancet 1982;2:564–566.

    Google Scholar 

  21. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension.Lancet 1981;2:539–543.

    Google Scholar 

  22. Ohman P, Aurell M, Asplund J, et al. A long term follow up of patients with essential hypertension treated with captopril.Acta Med Scand 1984;216:53–56.

    PubMed  Google Scholar 

  23. Weinberger MH. Antihypertensive therapy and lipids. Evidence, mechanisms and implications.Arch Intern Med 1985;145:1102–1105.

    PubMed  Google Scholar 

  24. Takabatake T, Ohta H, Maekawa M, Yamamoto Y, Ishida Y, Hara H, Hattori N. Effects of long term prazosine therapy on lipoprotein metabolism in hypertensive patients.Am J Med 1984;76 (Suppl 2A):113–116.

    PubMed  Google Scholar 

  25. Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Disability days associated with detection and treatment in the HDFP.Circulation 1979;50/60 (Suppl II):1167—II67—II71—.

    Google Scholar 

  26. Johnston ME, Gibson EG, Terry CW, et al. Effects of labelling on income, work, and social function among hypertensive employees.J Chronic Dis 1984;37:417–423.

    PubMed  Google Scholar 

  27. Jachuck SJ, Brierly H, Jachuck S, et al. The effect of hypotensive drugs on the quality of life.J Roy Coll Gen Pract 1982;32:103–105.

    Google Scholar 

  28. Croog SH, Levine S, Testa MA, et al. The effects of antihypertensive therapy of quality of life.N Engl J Med 1986;314:1657–1664.

    PubMed  Google Scholar 

  29. The 1988 report of the Joint National Committee on Detection, Evaluation and treatment of High Blood Pressure.Arch Inter Med 1988;148:1023–1038.

    Google Scholar 

  30. Zusman RM. Alternatives to traditional antihypertensive therapy (editorial).Hypertension 1986;8:837–842.

    PubMed  Google Scholar 

  31. Survey of Causes of Death (Rural). Office of the Registrar General India, Ministry of Home Affairs, New Delhi. Annual Report 1986, Series 3 No. 19.

  32. Shulman NB, Martinez B, Brogan C, et al. Financial cost as an obstacle to hypertension therapy.Am J Public Health 1986;76:1105–1108.

    PubMed  Google Scholar 

  33. Narins RG. Mild hypertension: A therapeutic dilemma.Kidney Int 1984;26:881–894.

    PubMed  Google Scholar 

  34. Health and Public Policy Committee, American College of Physicians. Philadelphia Pennsylvania. Biofeedback for hypertension.Ann Intern Med 1985;102:709–715.

    Google Scholar 

  35. Patel C, Marmot MG, Terry DJ, Carruthers M, Hunt B, Patel M. Trial of relaxation in reducing risk: Four year follow up.Br Med J 1985;290:1102–1106.

    Google Scholar 

  36. Patel C, Marmot MG. Stress management blood pressure, and quality of life.J Hypertens 1987;5 (Suppl 1):521–528.

    Google Scholar 

  37. Wenger NK. Quality of life issues in hypertension. Consequences of diagnosis and considerations in management.Am Heart J 1988;116:628–632.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Postgraduate Institute of Medical Education & Research, 160 012, Chandigarh, India

    Harinder K. Bali &  Inder S. Anand (Additional Professor of Cardiology)

Authors
  1. Harinder K. Bali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Inder S. Anand
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bali, H.K., Anand, I.S. Cost of antihypertensive treatment: A point of view from India. Cardiovasc Drug Ther 3, 761–765 (1989). https://doi.org/10.1007/BF01857628

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01857628

Key Words

Search

Navigation